EPIQ Capital Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.54M | Sell |
|
|||||
|
2024
Q3 | $641K | Sell |
|
|||||
|
2024
Q2 | $639K | Buy |
|
|||||
|
2024
Q1 | $897K | Sell |
|
|||||
|
2023
Q4 | $914K | Sell |
|
|||||
|
2023
Q3 | $1.04M | Sell |
|
|||||
|
2023
Q2 | $1.4M | Sell |
|
|||||
|
2023
Q1 | $1.5M | Sell |
|
|||||
|
2022
Q4 | $673K | Sell |
|
|||||
|
2022
Q3 | $2.73M | Sell |
|
|||||
|
2022
Q2 | $7.27M | Sell |
|
|||||
|
2022
Q1 | $20M | Sell |
|
|||||
|
2021
Q4 | $53.9M | Buy |
|
|||||
|
2021
Q3 | $362M | Buy |
|
|||||
|
2021
Q2 | $200M | Buy |
|
|||||
|
2021
Q1 | $132M | Buy |
|
|||||
|
2020
Q4 | $97.4M | Buy |
|
|||||
|
2020
Q3 | $171M | Buy |
|
|||||
|
2020
Q2 | $155M | Buy |
|
|||||
|
2020
Q1 | $146M | Buy |
|
|||||
|
2019
Q4 | $176M | Buy |
|